1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 09 MARCH 2015

Cancer Drug News 09 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Novartis Will Maximise GSK Oncology Revenues
Industry Brief - Eisai/Merck Collaborate To Explore Keytruda, Lenvima And Halaven Combination Regimens
Industry Trend Analysis - Spectrum Bolsters Pipeline With Poziotinib Agreement
Industry Brief - Radius Acquires Japanese Rights To RAD1901; Appoints SVP/Head Of Global Oncology
Industry Brief - BioLineRx Files Application To Initiate BL-8040 Phase IIb Trial In AML
Industry Brief - Incyte Sponsors First US Observational Study For PV
Industry Brief - AOP Orphan Completes Enrolment In Phase III Trial Of Ropeginterferon Alfa 2b For PV
Industry Brief - Pacritinib Phase III Trial Meets Primary Endpoint In MF
Industry Brief - FDA Accepts Spectrum's NDA Filing For Captisol-Enabled Melphalan
Industry Trend Analysis - Anti-PD1 Race Continues Despite BMS' NSCLC Approval Win
Industry Brief - Combination Cell-Gene Therapy For LC To Be Tested In UK Patients
Industry Brief - ACD's RNAscope Technology Supports Merrimack's MM-121 Phase II Trial
Industry Trend Analysis - BMS Highlights Potential Of Cancer Vaccines With Bavarian Nordic Deal
Industry Brief - CHMP Issues Positive Opinion For Avastin Plus CT In Advanced CC
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Fallopian Tube Cancer
Industry Brief - ORYX Completes Phase I/IIa Trial Of VicOryx In HPV-Positive Cancers
Industry Brief - Bayer Halts Enrolment In Regorafenib Phase III Trial For CRC
Industry Brief - Tivozanib Shows Longer PFS Over Bevacizumab In Phase II CRC Trial
Industry Brief - ORYX Completes Phase I/IIa Trial Of MicOryx In MSI-H Colorectal Cancer
Industry Brief - DelMar Granted US Patent NoA Covering VAL-083
Industry Brief - Heidelberg Secures EU Grant To Develop Tumour-Specific Peptide-Drug Conjugates
Industry Trend Analysis - Roche Most At Risk From Upcoming Biosimilar Oncology Market
Industry Brief - TG/Checkpoint Enter Collaboration For Novel Immuno-Oncology Targeted Abs
Industry Trend Analysis - Zarxio's Approval Will See Focus Shift To Battle For Market Acceptance
Industry Brief - Aura Raises Funds To Advance Rare Ocular Cancer Therapies Into Clinic
Industry Trend Analysis - AbbVie Makes Surprise Acquisition Of Pharmacyclics

Table Of Contents

Cancer Drug News 09 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in Sweden

  • February 2017
    8 pages
  • Therapy  

    Hormone  

    Antidiabetics  

  • Sweden  

View report >

Contraceptive Market in the Netherlands

  • February 2017
    8 pages
  • Contraceptive  

  • Netherlands  

View report >

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Diabetes Statistics

4 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.